Overview


According to FutureWise analysis the market for A.V. fistula needles in 2023 is US$ 0.21 billion, and is expected to reach US$ 0.43 billion by 2031 at a CAGR of 9.56%.

An arteriovenous (AV) fistula needle is a specialized medical device used in haemodialysis, a life-saving treatment for individuals with kidney failure. The AV fistula is a surgically created connection between an artery and a vein in the patient's arm. It allows for the efficient removal and return of blood during the dialysis process. The AV fistula needle is specifically designed for accessing the AV fistula during haemodialysis sessions. It consists of a sharp needle attached to a tubing set. The needle is inserted into the AV fistula, allowing blood to be withdrawn from the patient's body and then returned after the dialysis machine has cleansed it.

The proper insertion of AV fistula needles is crucial to ensure successful haemodialysis treatments. Healthcare professionals undergo training to master the technique of needle insertion, aiming to minimize complications such as bleeding, infection, and damage to the AV fistula. Strict adherence to sterile techniques and aseptic procedures is essential to prevent infections and maintain the long-term viability of the AV fistula.

FutureWise Market Research has published a report that provides an insightful analysis of A.V. Fistula Needles Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the A.V. Fistula Needles Market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Nipro
  • Fresenius
  • B. Braun
  • JMS
  • Kawasumi Lab
  • NxStage Medical
  • Asahi Kasei
  • Beldico
  • Farmasol
  • Hemoclean
  • Bain Medical
  • Tianjin Pharma
  • Hongda Medical
  • Far East Medical
  • Baihe Medical

(Note: The list of the major players will be updated with the latest market scenario and trends)

AV fistula needles are a necessity for a safe and effective means of accessing the AV fistula to perform hemodialysis. The AV fistula is contemplated the gold standard for vascular access in hemodialysis due to its superior long-term outcomes and lower risk of complications than other access methods, such as central venous catheters or arteriovenous grafts. AV fistula needles are designed with features allowing successful and comfortable needle insertion into the AV fistula. These features include sharp, beveled needles to penetrate the thickened vessel wall, appropriate needle lengths and gauges to accommodate different patient needs, and secure connection systems to ensure proper blood flow during dialysis. The above-mentioned factors are expected to drive the market growth. Moreover, manufacturers are continuously developing AV fistula needles with improved features, such as enhanced sharpness, bevel geometry, and needle tip configurations. These advancements aim to facilitate easier and more comfortable needle insertion into the AV fistula, minimizing pain and trauma for patients during the hemodialysis procedure. However, the risk of infection associated with AV fistula needles is expected to hinder market growth. Despite adherence to strict aseptic techniques, there is always a risk of introducing bacteria or other pathogens during needle insertion. Infections can lead to localized or systemic complications, requiring prompt medical attention and potential interruption of hemodialysis treatments, further restraining the market.

By Type

  • 15 Gauge
  • 16 Gauge
  • 17 Gauge
  • Other

By Application

  • Dialysis Center
  • Home Dialysis
  • Other

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to well established healthcare system as well as awareness among individuals is driving the market growth in the region. Also, rising incidence of end stages renal disease along with rising ageing population in the region leading to haemodialysis is further driving the market growth in the region. 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the A.V. Fistula Needles Market By Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  A.V. Fistula Needles Market Variables, Trends & Scope
    • 1. Market Lineage Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Type Overview
      6. Regulatory Framework
          6.1. Reimbursement Framework
          6.2. Standards and Compliances

  • 5.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    • 1. Market Dynamics
          1.1. Market Driver Analysis
              1.1.1. Increasing focus of A.V. Fistula Needles Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
          1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
          1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  A.V. Fistula Needles Market Analysis Tools
    • 1. Industry Analysis - Porter’s
          1.1. Supplier Power
          1.2. Buyer Power
          1.3. Substitution Threat
          1.4. Threat from New Entrants
          1.5. Competitive Rivalry
      2. Pestel Analysis
          2.1. Political Landscape
          2.2. Environmental Landscape
          2.3. Social Landscape
          2.4. Type Landscape
          2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
          3.1. Joint Ventures
          3.2. Mergers and Acquisitions
          3.3. Licensing and Partnership
          3.4. Type Collaborations
          3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies

  • 7.  A.V. Fistula Needles Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •     1. 15 Gauge
          2. 16 Gauge
          3. 17 Gauge
          4. Other

  • 8.  A.V. Fistula Needles Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •     1. Dialysis Center
          2. Home Dialysis
          3. Other

  • 9.  North America A.V. Fistula Needles Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •     1. Introduction
          2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
              2.1. U.S.A
              2.2. Canada
              2.3. Mexico
          3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.  Latin America A.V. Fistula Needles Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •     1. Introduction
          2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
              2.1. Brazil
              2.2. Venezuela
              2.3. Argentina
              2.4. Rest of Latin America
          3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.  Europe A.V. Fistula Needles Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •     1. Introduction
          2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
              2.1. Germany
              2.2. U.K
              2.3. France
              2.4. Italy
              2.5. Spain
              2.6. Russia
              2.7. Poland
              2.8. Rest of Europe
          3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.  Asia Pacific A.V. Fistula Needles Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •     1. Introduction
          2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
              2.1. Japan
              2.2. China
              2.3. India
              2.4. Australia and New Zealand
              2.5. ASEAN
              2.6. Rest of Asia Pacific
          3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.  Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •     1. Introduction
          2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
              2.1. Saudi Arabia
              2.2. UAE
              2.3. South Africa
              2.4. Egypt
          3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.  Market Share Analysis and Competitive Landscape
    •     1. Global Landscape - Key Players, Revenue and Presence
          2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
          3. Global Emerging Companies
          4. North America - Market Share Analysis and Key Regional Players
          5. Europe - Market Share Analysis and Key Regional Players
          6. Asia Pacific - Market Share Analysis and Key Regional Players
          7. Global Key Player - Growth Matrix

  • 15.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •       1. Nipro
              1.1. Company Overview
              1.2. Product Portfolio
              1.3. SWOT Analysis
              1.4. Financial Overview
              1.5. Strategic Overview
            2. Fresenius
              2.1. Company Overview
              2.2. Product Portfolio
              2.3. SWOT Analysis
              2.4. Financial Overview
              2.5. Strategic Overview
            3. B. Braun
              3.1. Company Overview
              3.2. Product Portfolio
              3.3. SWOT Analysis
              3.4. Financial Overview
              3.5. Strategic Overview
            4. JMS
              4.1. Company Overview
              4.2. Product Portfolio
              4.3. SWOT Analysis
              4.4. Financial Overview
              4.5. Strategic Overview
            5. Kawasumi Lab
              5.1. Company Overview
              5.2. Product Portfolio
              5.3. SWOT Analysis
              5.4. Financial Overview
              5.5. Strategic Overview
            6. NxStage Medical
              6.1. Company Overview
              6.2. Product Portfolio
              6.3. SWOT Analysis
              6.4. Financial Overview
              6.5. Strategic Overview
            7. Asahi Kasei
              7.1. Company Overview
              7.2. Product Portfolio
              7.3. SWOT Analysis
              7.4. Financial Overview
              7.5. Strategic Overview
            8. Beldico
              8.1. Company Overview
              8.2. Product Portfolio
              8.3. SWOT Analysis
              8.4. Financial Overview
              8.5. Strategic Overview
            9. Farmasol
              9.1. Company Overview
              9.2. Product Portfolio
              9.3. SWOT Analysis
              9.4. Financial Overview
              9.5. Strategic Overview
            10. Hemoclean
              10.1. Company Overview
              10.2. Product Portfolio
              10.3. SWOT Analysis
              10.4. Financial Overview
              10.5. Strategic Overview
            11. Bain Medical
              11.1. Company Overview
              11.2. Product Portfolio
              11.3. SWOT Analysis
              11.4. Financial Overview
              11.5. Strategic Overview
            12. Tianjin Pharma
              12.1. Company Overview
              12.2. Product Portfolio
              12.3. SWOT Analysis
              12.4. Financial Overview
              12.5. Strategic Overview
            13. Hongda Medical
              13.1. Company Overview
              13.2. Product Portfolio
              13.3. SWOT Analysis
              13.4. Financial Overview
              13.5. Strategic Overview
            14. Far East Medical
              14.1. Company Overview
              14.2. Product Portfolio
              14.3. SWOT Analysis
              14.4. Financial Overview
              14.5. Strategic Overview
            15. Baihe Medical
              15.1. Company Overview
              15.2. Product Portfolio
              15.3. SWOT Analysis
              15.4. Financial Overview
              15.5. Strategic Overview

  • 16.  Pre and Post COVID-19 Impact
    •     1. Positive influence on the healthcare industry
          2. The financial disruption of the manufacturing sector
          3. Impact of COVID-19 on emerging companies
          4. Significant mandates in the healthcare regulations initiated by administrations
          5. The overall economic slowdown of the developing and developed nations

  • 17.  FutureWise SME Key Takeaway Points for Client
    • .

Related Market

Arteriovenous Fistula Treatment Market

Read More

Anal Fistula Treatment

Read More
Partner

Our Clients